HALO logo
halo search icon
MSB
Mesoblast Limited

MSB · Mesoblast Limited

2.37

AUD
-0.03 (-1.25%)
19/08/2026 04:10:13 PM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

AU$3.08B

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Franking

0%

MQV Rating

5Very Weak

As at 19/08/2026 04:10:13 PM

Price Chart

Description

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.

  • All-Companies
  • All-Consensus
  • EMA 125 Breakup
  • Fakey Shakey - Short
  • Fakey Shakey - Short (Realtime)
  • GROWTH AUS
  • HALO 200
  • HALO Ords
  • HALO Small
  • Hammer Bullish (Realtime)

Key Fundamentals

EPS 3 yr Growth

-36.60%

EBITDA Margin

-326.40%

Operating Cashflow

-$57m

Free Cash Flow Return

-9.20%

ROIC

-16.70%

Interest Coverage

-2.40

Quick Ratio

1.80

Performance

52 weeks range

Low 1.88 - 3.31

Trade Value (12mth)

US$1,716,044.00

1 week

-0.41%

1 month

3.45%

YTD

-13.36%

1 year

0.84%

All time high

9.42

Additional Data

Shares Outstanding (Fully Diluted)

1,292m

HALO Sector

Healthcare

Next Company Report Date

02-Sep-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

7.60

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Neutral

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
17 August 26ASXD
13 August 26ASXD
07 August 26ASXD
05 August 26ASXD
03 August 26ASXD

Key Stakeholders

NameTitle
Gregory GeorgeIndividual
Silviu ItescuIndividual
William GueckIndividual
Josaka Investments Pty Ltd.Private Company
Eric A. RoseIndividual

See beyond the curve.

One solution for research, investing and portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of Mesoblast Limited (MSB:ASX)?
Halo FAQ
The current share price of Mesoblast Limited (MSB:ASX) is AUD$2.37.
2
What is the 52-week high share price for Mesoblast Limited (MSB:ASX)?
Halo FAQ
The 52-week high share price for Mesoblast Limited (MSB:ASX) is AUD$3.31.
3
What is the 52-week low share price for Mesoblast Limited (MSB:ASX)?
Halo FAQ
The 52-week low share price for Mesoblast Limited (MSB:ASX) is AUD$1.88.
4
What is the dividend yield for Mesoblast Limited (MSB:ASX)?
Halo FAQ
Mesoblast Limited (MSB:ASX) does not pay a dividend.
5
What was Mesoblast Limited (MSB:ASX) last dividend payment?
Halo FAQ
Mesoblast Limited (MSB:ASX) does not pay a dividend.
6
What is the franking level for Mesoblast Limited (MSB:ASX)?
Halo FAQ
Mesoblast Limited (MSB:ASX) has a franking level of 0.00%.
7
In which sector is Mesoblast Limited (MSB:ASX) classified?
Halo FAQ
Mesoblast Limited (MSB:ASX) is classified in the Healthcare.